Department of Biochemistry & Molecular Biophysics, Kansas State University, Manhattan, Kansas 66506.
Department of Medical Microbiology, University Medical Center Utrecht, 3584 CX Utrecht, The Netherlands.
J Biol Chem. 2020 May 29;295(22):7753-7762. doi: 10.1074/jbc.RA120.013601. Epub 2020 Apr 17.
Members of the EAP family of immune evasion proteins potently inhibit the neutrophil serine proteases (NSPs) neutrophil elastase, cathepsin-G, and proteinase-3. Previously, we determined a 1.8 Å resolution crystal structure of the EAP family member EapH1 bound to neutrophil elastase. This structure revealed that EapH1 blocks access to the enzyme's active site by forming a noncovalent complex with this host protease. To determine how EapH1 inhibits other NSPs, we studied here the effects of EapH1 on cathepsin-G. We found that EapH1 inhibits cathepsin-G with a of 9.8 ± 4.7 nm Although this value is ∼466-fold weaker than the for EapH1 inhibition of neutrophil elastase, the time dependence of inhibition was maintained. To define the physical basis for EapH1's inhibition of cathepsin-G, we crystallized EapH1 bound to this protease, solved the structure at 1.6 Å resolution, and refined the model to and values of 17.4% and 20.9%, respectively. This structure revealed a protease-binding mode for EapH1 with cathepsin-G that was globally similar to that seen in the previously determined EapH1-neutrophil elastase structure. The nature of the intermolecular interactions formed by EapH1 with cathepsin-G differed considerably from that with neutrophil elastase, however, with far greater contributions from the inhibitor backbone in the cathepsin-G-bound form. Together, these results reveal that EapH1's ability to form high-affinity interactions with multiple NSP targets is due to its remarkable level of local structural plasticity.
EAP 家族的免疫逃逸蛋白成员能够强烈抑制中性粒细胞丝氨酸蛋白酶(NSP),包括中性粒细胞弹性蛋白酶、组织蛋白酶-G 和蛋白酶-3。先前,我们确定了 EAP 家族成员 EapH1 与中性粒细胞弹性蛋白酶结合的 1.8Å分辨率晶体结构。该结构表明,EapH1 通过与宿主蛋白酶形成非共价复合物来阻止弹性蛋白酶进入其活性部位。为了确定 EapH1 如何抑制其他 NSP,我们在此研究了 EapH1 对组织蛋白酶-G 的影响。我们发现 EapH1 以 9.8±4.7nm 的 Ki 值抑制组织蛋白酶-G。虽然这个 Ki 值比 EapH1 抑制中性粒细胞弹性蛋白酶的 Ki 值弱约 466 倍,但抑制的时间依赖性得以维持。为了确定 EapH1 抑制组织蛋白酶-G 的物理基础,我们将 EapH1 与该蛋白酶结合进行结晶,以 1.6Å 的分辨率解决结构,并将模型细化至 和 分别为 17.4%和 20.9%。该结构揭示了 EapH1 与组织蛋白酶-G 的蛋白酶结合模式,在全局上与先前确定的 EapH1-中性粒细胞弹性蛋白酶结构相似。然而,EapH1 与组织蛋白酶-G 形成的分子间相互作用的性质与与中性粒细胞弹性蛋白酶的性质有很大不同,与弹性蛋白酶结合形式相比,抑制剂骨架的贡献要大得多。总之,这些结果表明,EapH1 形成与多种 NSP 靶标高亲和力相互作用的能力归因于其显著的局部结构可塑性。